FDA | Page 4 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
February 10, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, FEBRUARY 10, 2026

FDA

FDA

Since he lost the presidential election, Trump has been issuing and finalizing a host of rule changes in areas ranging from energy, healthcare to immigration in a bid to bolster key areas of his agenda prior to his departure from the White House in January Photo: BSS/AFP

Trump, ahead of FDA, says Moderna's Covid-19 vaccine has been approved

US plans to OK 2nd Covid-19 vaccine after panel endorsement

US plans to OK 2nd Covid-19 vaccine after panel endorsement

Photo: Collected.

With US now in hand, BioNTech CEO looks for more vaccine production

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019/ Reuters

US FDA authorises Pfizer Covid-19 vaccine for emergency use

US FDA 'working rapidly' on Pfizer Covid-19 vaccine decision

US FDA 'working rapidly' on Pfizer Covid-19 vaccine decision

Moderna's Covid-19 vaccine may get emergency nod 24-72 hrs after FDA panel meet -CEO

Moderna's Covid-19 vaccine may get emergency nod 24-72 hrs after FDA panel meet -CEO

AstraZeneca to discuss with US FDA changing vaccine trial design

AstraZeneca to discuss with US FDA changing vaccine trial design

It will be a while before Covid-19 is well-controlled, vaccine or not. In the meantime, testing will be crucial. Photo: Bloomberg

FDA approves first Covid-19 test kit for home use

A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Photo:Reuters

FDA widens US safety inquiry into AstraZeneca coronavirus vaccine

Photo: Collected

Beximco Pharma’s antiarrhythmic drug flecainide receives US FDA approval

'Dangerous with limited use', FDA warns against ultraviolet UVC sanitisers

'Dangerous with limited use', FDA warns against ultraviolet UVC sanitisers

Top FDA official says would resign if agency rubber-stamps an unproven Covid-19 vaccine

Top FDA official says would resign if agency rubber-stamps an unproven Covid-19 vaccine

Power-generating windmill turbines are pictured during sunset at a wind park in Campeneac, France, September 3, 2019/ Reuters

France provides Bangladesh €100m for renewable energy projects

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net